Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
US Department of Justice

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019918

« Back to Dashboard

NDA 019918 describes NIX, which is a drug marketed by Glaxosmithkline and Medtech Products and is included in two NDAs. It is available from one supplier. Additional details are available on the NIX profile page.

The generic ingredient in NIX is permethrin. There are five drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the permethrin profile page.
Summary for 019918
Applicant:Medtech Products
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 019918
Suppliers and Packaging for NDA: 019918
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NIX permethrin LOTION;TOPICAL 019918 NDA Insight Pharmaceuticals 63736-024 E 63736-024-04
NIX permethrin LOTION;TOPICAL 019918 NDA Insight Pharmaceuticals 63736-024 E 63736-024-02

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:LOTION;TOPICALStrength1%
Approval Date:May 2, 1990TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.